Evaluation of epidermal growth factor receptors in bladder tumours
- PMID: 3426916
- PMCID: PMC2001894
- DOI: 10.1038/bjc.1987.238
Evaluation of epidermal growth factor receptors in bladder tumours
Abstract
Epidermal growth factor (EGF) receptor expression in 31 primary human bladder tumours was quantitated using both structural and functional assays and the EGF receptor gene in the same tumours was analyzed by Southern blot analysis. Immunocytochemical studies using the EGFR1 monoclonal antibody (Mab) showed a significant correlation between EGF receptor levels and the stage and grade of the tumours. Autophosphorylation assays employed to evaluate the receptor's tyrosine kinase activity gave results which in general were consistent with the immunocytochemical data. Using internally controlled immunocytochemical studies with two Mabs and Southern blot analysis of DNA isolated from the tumours, no evidence was obtained for the production of truncated receptors similar to those encoded by the v-erb-B oncogene. Gene amplification was not found in any of the superficial tumours, but one invasive tumour with high EGF receptor expression had an 8-10 fold amplification of the EGF receptor gene. The EGF receptor isolated from this tumour showed a normal pattern of tyrosine phosphorylation at all three major autophosphorylation sites. Our detailed study is consistent with the correlation previously found between EGF receptor expression and stage and grade of bladder tumours, and suggests that at this level of analysis EGF receptors in bladder tumours are not abnormal in structure or size, autophosphorylation activity, or gene structure.
Similar articles
-
Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.Br J Cancer. 1991 Jun;63(6):967-70. doi: 10.1038/bjc.1991.211. Br J Cancer. 1991. PMID: 1712624 Free PMC article.
-
Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer.J Urol. 1992 Jan;147(1):274-7. doi: 10.1016/s0022-5347(17)37212-9. J Urol. 1992. PMID: 1729545
-
Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.Lancet. 1985 Feb 16;1(8425):366-8. doi: 10.1016/s0140-6736(85)91386-8. Lancet. 1985. PMID: 2857420
-
Altered expression of epidermal growth factor receptors in human bladder and lung tumours.Princess Takamatsu Symp. 1986;17:183-94. Princess Takamatsu Symp. 1986. PMID: 3332010 Review.
-
Members of the EGF receptor family in normal and pathological epidermis.Folia Med (Plovdiv). 2009 Jul-Sep;51(3):5-17. Folia Med (Plovdiv). 2009. PMID: 19957557 Review.
Cited by
-
Role of tyrosine kinases in bladder cancer progression: an overview.Cell Commun Signal. 2020 Aug 14;18(1):127. doi: 10.1186/s12964-020-00625-7. Cell Commun Signal. 2020. PMID: 32795296 Free PMC article. Review.
-
Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma.Virchows Arch A Pathol Anat Histopathol. 1990;416(4):343-9. doi: 10.1007/BF01605295. Virchows Arch A Pathol Anat Histopathol. 1990. PMID: 2106751
-
Relationship of epidermal growth factor receptor detectability with the A, B, H blood group antigens. Emphasis on normal and neoplastic urothelium.Am J Pathol. 1991 Jul;139(1):131-7. Am J Pathol. 1991. PMID: 1713019 Free PMC article.
-
Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants.Mol Cell Biol. 1992 Feb;12(2):491-8. doi: 10.1128/mcb.12.2.491-498.1992. Mol Cell Biol. 1992. PMID: 1346334 Free PMC article.
-
Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer.Br J Cancer. 1995 Jan;71(1):196-200. doi: 10.1038/bjc.1995.40. Br J Cancer. 1995. PMID: 7819039 Free PMC article.